A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

Article English OPEN
Drukker, CA ; Bueno-de-Mesquita, JM ; Retèl, VP ; van Harten, WH ; van Tinteren, H ; Wesseling, J ; Roumen, RMH ; Knauer, M ; van 't Veer, LJ ; Sonke, GS ; Rutgers, EJT ; van de Vijver, MJ ; Linn, SC (2013)
  • Publisher: Blackwell Publishing Ltd
  • Journal: International Journal of Cancer. Journal International du Cancer, volume 133, issue 4, pages 929-936 (issn: 0020-7136, eissn: 1097-0215)
  • Related identifiers: pmc: PMC3734625, doi: 10.1002/ijc.28082
  • Subject: Early Detection and Diagnosis | adjuvant systemic treatment | breast cancer | gene expression profiling | prognosis prediction

The 70-gene signature (MammaPrint™) has been developed on retrospective series of breast cancer patients to predict the risk of breast cancer distant metastases. The microarRAy-prognoSTics-in-breast-cancER (RASTER) study was the first study designed to prospectively eva... View more
Share - Bookmark